0000039205 00000 n The vaccine is only approved for use when an H1N1 influenza pandemic has been officially declared by the World Health Organization (WHO) or European Union (EU). 0000021537 00000 n 0000002787 00000 n 0000102388 00000 n 0000011743 00000 n CSL H1N1 Pandemic Influenza Vaccine is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. 0000073994 00000 n endstream endobj 114 0 obj <. %%EOF 134 0 obj <>/Filter/FlateDecode/ID[<18BEF9D6870DCE4AAB0252DBB3B8EB4B>]/Index[113 38]/Info 112 0 R/Length 100/Prev 71815/Root 114 0 R/Size 151/Type/XRef/W[1 2 1]>>stream 0000002070 00000 n 0000063553 00000 n �d���w�o�o);�t���K�9Gv�Y���SfE��6�����6�d:��N��#�=��#�=��#�=��#�=��#�Ȗy�L��#���a�}��t2�g=z�i�0{�=̞f�����i�0{�=̞N���é�������������������������EO�s)�RΥ�\|G�w�쏢?���ߤ�?��(���>�]�'�?� 4���@s�9�`4���@g�3���rl:a�=V�Z�!دu\��1-���1�]�ڶ�_?��l���` �� endstream endobj 1234 0 obj<> endobj 1235 0 obj<> endobj 1236 0 obj[/Separation/All/DeviceCMYK<>] endobj 1237 0 obj<>stream 0000003602 00000 n ]0Y����v��ϱ�q���k�x�oc�1���,s۴�������L{�_�x�w����~�{�i�ۧM���~�M��l����g�n��/���®׶�'��ߪ�{u�6����t���/i̿'~߇h��zIK�7�:Tu��M�H���i[��5����O�G5�b��^,T�^�M�/��tJ�3{�W�W�� The 2009 H1N1 pandemic stimulated a nationwide response that included a mass vaccination effort coordinated at the federal, state, and local levels. %PDF-1.5 %���� ">�U���v1o3u�����8��01 H�\��n�0ཟ��vQ����FB��JY̏&3@�I�@�,���É:� ��? )ݐ3+��6�⬷h��-v�����QOA5��m?������?C�~F[�T"��N��1�:֊�@�"3.捦N|�"A�ׯȌ�y�-NdI��~A��)%��4Q�`4m� 0000002901 00000 n 113 0 obj <> endobj %PDF-1.6 %���� The pandemic influenza is a new virus, and virtually everyone is susceptible to infection from it. Influenza vaccines are one of the most effective ways to protect people from contracting illness during influenza epidemics and pandemics. 0000004595 00000 n �dh:�b I8�z`Р��8���&����n�������I��3��e3u�(h�y��f���$Sf8�+��żMS�"�M%F��a���zEv�1o3u!��z8�+2�b�f��/z�W��n�6�͌fL���P��cl?�^�r�km���T���3��Q��wӶ���IOB՟!n?�IshEp��R���1o3ͣׯ!���Ϩ�u�~c�a��P�s��'v��k��MK*�zx7��LIgm������������n��i8�+2sc������אf|�gT���0V��4�M�t����U�����E[AOEO�R��ɣ��P�T����$�O;�H�va�P�/~�|�=yr�����=}v� ⫏�����R���X^��� 0000001865 00000 n 0000023538 00000 n 0000043610 00000 n 0�agn�bX�k������i��C-s^uJ�s7�AW��;+�Ų��-�j��� ~!�a2���NT1�Cž. trailer <<4F397BBF7CFD11DF892500145103AA78>]>> startxref 0 %%EOF 1288 0 obj<>stream 0000094871 00000 n 0000095205 00000 n 0000022923 00000 n �00 0000031478 00000 n For more information, call the special media telephone line:+41 22 791 5000E-mail:flumedia@who.int, Safety for pregnant women and children, testing, side effects, adverse effects, risks falsely associated with vaccines (thiomersal, adjuvants, Guillain Barre syndrome), How vaccines are given, combining with seasonal influenza vaccine, Global production capacity, priorities for vaccination, WHO actions for more equitable access. 150 0 obj <>stream 0000063181 00000 n 0000094657 00000 n 0000022002 00000 n :�u'�@���݇�v/a��}�}����t�������?�N~Y�rws{���f���,��"?���p�M�dtB��.�T"H�C��E��~�� ��"�Q�{ZM�$��f�_��N�m&. The science of vaccine development has advanced since the 2009 outbreak of H1N1 or swine flu. 0000052219 00000 n Influenza-Impfstoff (H1N1)v (Ganzvirus, in Vero-Zellen hergestellt, inaktiviert) Dies ist eine Zusammenfassung des Europäischen Öffentlichen Beurteilungsberichts (EPAR) für Celvapan. In 2009, the H1N1 virus, also known as Swine Flu, killed as many as 284,000 people worldwide. 0000063251 00000 n 0000004757 00000 n 0000020759 00000 n 0000021274 00000 n 0000022790 00000 n 0000078501 00000 n 0000094727 00000 n 0000102458 00000 n 0000031945 00000 n M^�tR�֢�U���Q�,먲��w3�-��t"��$uGKJD 0000102126 00000 n The virus is harvested from the eggs, purified by zonal centrifugation, inactivated with beta-propiolactone and disrupted with sodium taurodeoxycholate to produce split virion particles. 0 0000027767 00000 n 0000002217 00000 n The vaccine was one of the H1N1 vaccines approved for use by the European Commission in September 2009, upon the recommendations of the European Medicines Agency (EMEA). influenza A(H1N1) vaccine. 0000089135 00000 n 0000004210 00000 n 0000063800 00000 n �7��^�c�@� 0000035727 00000 n 0000032085 00000 n 0000007723 00000 n ��p�}/S^m�VXO�j��Q ��ϊ`)�K�K�t�6{�������w,�s!qs�1'%�4�����z0$���3���Uk0�K���֬&�m� @xݐ��D�2ɴ� F�ɓ�eZO��k���c�V�(�e�83� �a6��L�a�.�p��r�t�b$B�ȏ���YkM. 0000002985 00000 n ?/?�n�;z�>�C�]�)k#0щ� ��+�����\�u�t|tv��t�����_q�x��������x�⅔2u9�G���O��/�5�f������O��S�O��e��b�/�������7�V5��$�y��}��گ�}uv|��ϟ͸�{�17�������N�Ξ�l$f~���������c���y�>;=��8-��US�:M�F�t�J��f1 '�J(���B��S��~�yA'�PvJ8�ɠ!^X�qK�T^�Yم advertisement. x�b``�a``O``c`4Ie�g@ ~���՟�p�j[fW �f�c�"Cz�w�y����l�j ʱ��@XZF@x � 0000023196 00000 n h�bbd``b`z$�X3���`��ւgWH�ăXn �D,\Q ��@�;$vHli�M C� �+L�@#����O ڞL The novel influenza A virus known as H1N1 … In den USA steht ein in die Nase (intranasal) zu verabreichender Lebendimpfstoff des Herstellers MedImmune zur Verfügung. 0000027583 00000 n 0000023510 00000 n 0000015848 00000 n 0000021187 00000 n 0000022656 00000 n 0000102766 00000 n h�b```�y�. 0000062928 00000 n *��l�H3�z� �@� endstream endobj 1287 0 obj<>/Size 1227/Type/XRef>>stream 0000031506 00000 n This article examines a sampling of state and local efforts during the pandemic in order to better prepare for future public health emergencies involvi … 0000088583 00000 n 1227 0 obj <> endobj xref 1227 62 0000000016 00000 n Mit einem speziellen Applikator werden 0,1 ml Impfstoff in jedes Nasenloch appliziert. H��W�n7����~����d��ȉW���`!��X��I'^���)������BlÞ�3U��)����]�J��)��pNuwW��ݻ��Ʌ�N. 0000102738 00000 n x���A �4���+6��>��m{�d�Ks=�!ⱽ'� ^;� endstream endobj 1228 0 obj<>/ViewerPreferences<>/Metadata 28 0 R/Pages 27 0 R/StructTreeRoot 30 0 R/Type/Catalog>> endobj 1229 0 obj<>/Font<>/ProcSet[/PDF/Text]/ExtGState<>>>/Type/Page>> endobj 1230 0 obj<> endobj 1231 0 obj<> endobj 1232 0 obj<> endobj 1233 0 obj<>stream These vaccines will boost immunity against the new influenza, and help ensure public health as the pandemic evolves. 0000063400 00000 n 0000088831 00000 n ��ea��`:������1:�����6�Z@Z�E�"߁z��3.`lc�a�e�`�g For more information, call the special media telephone line: Coronavirus disease outbreak (COVID-2019), Coronavirus disease outbreak (COVID-19) », Production and availability of pandemic (H1N1) 2009 vaccines, Full list of briefing notes related to H1N1 vaccines, Statement from WHO Global Advisory Committee on Vaccine Safety about the safety profile of pandemic influenza A (H1N1) 2009 vaccines, Summary of available potency testing reagents for Pandemic (H1N1) 2009 virus vaccines, Full list of guidance documents related to H1N1 vaccines. 0000039275 00000 n Safety of pandemic (H1N1) 2009 vaccines Safety for pregnant women and children, testing, side effects, adverse effects, risks falsely associated with vaccines (thiomersal, adjuvants, Guillain Barre syndrome) Use of pandemic (H1N1) 2009 vaccines How vaccines are given, combining with seasonal influenza vaccine 0000020017 00000 n 0000094899 00000 n �m�"2|� |L����m�/~6���֐d�;�튺�TC&���� 0000004322 00000 n 0000031806 00000 n 0000001536 00000 n 0000094409 00000 n endstream endobj startxref a\Ù̠Ù���7�i�*��3 V�30,Ҍ@�I@����3��rL�� R���� ��% �yG MedImmune Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal. The H1N1 vaccine program in 2009 and 2010, with which we were both involved, provides a model for doing this.